Healthcare Pharmaceutical Biotech

Spago Nanomedical Interim Report January-March 2026

May 7, 2026 2:20 AM

Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) JANUARY - MARCH IN BRIEF Net sales for the quarter amounted to KSEK 22 (KSEK 338) The loss for the quarter amounted to KSEK -6,798 (KSEK -7,435) Operating expenses for the quarter amounted to KSEK -7,967 (KSEK -8,964) Earnings per share, before and after dilution, for the quarter amounted to SEK -0.01 (SEK -0. 02) Cash and cash equivalents at the end of the quarter amounted to KSEK 25,923 (KSEK 26,578)...

Read more

As Wall Street Celebrates "Marijuana Rescheduling," the Real Story Is Emerging: The DEA's Own Final Rules Collide With the Political Hype

May 7, 2026 1:40 AM

While marijuana stock promoters and political commentators celebrate the idea of federal cannabis rescheduling as if legalization is imminent, a far more dangerous reality is beginning to surface behind closed doors in Washington: The United States government may now be trapped inside its own regulatory contradictions. For nearly a decade, companies like MMJ International Holdings and its subsidiary MMJ BioPharma Cultivation followed the federal...

Read more

SteelPower Reviewed: Don't Buy SteelPower Pills Before Reading This Male Vitality Formula Report First!

May 6, 2026 10:45 PM

Disclaimers: This content is a paid promotional advertorial provided for informational purposes only and should not be interpreted as medical advice, diagnosis, or treatment guidance. This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. SteelPower Consumer Report Explores Male Vitality Formula, Ingredient Transparency, and Daily Wellness Support Here is the situation...

Read more

DirectMeds ED 2026: New Triple-Ingredient Sublingual Prescription Formula (Get Approved In Minutes?)

May 6, 2026 8:45 PM

Advertorial / Affiliate Disclosure: This article contains affiliate links. If a purchase is made through links in this article, a commission may be earned at no additional cost to you. This article is for informational purposes only and does not constitute medical advice. Prescription ED medications require evaluation by a licensed healthcare provider. Individual results vary. Prescription approval is not guaranteed. DirectMax ED 2026: Is Direct...

Read more

Novi GLP-1 2026: Pricing From $133, Cancellation Terms Most Guides Skip, and What the FDA Compounding Deadline Means Before You Enroll

May 6, 2026 8:40 PM

Advertorial Disclosure: This is sponsored advertising content produced by an independent publisher in connection with a marketing arrangement. It is not independent medical advice, does not guarantee eligibility, prescriptions, pricing, availability, or results, and is not a substitute for speaking with a licensed healthcare professional. This content contains affiliate links. If a purchase is made through links in this article, a commission may...

Read more

Action Behavior Centers Marks Autism Acceptance Month with Nationwide Celebrations and a Renewed Commitment to Inclusion

May 6, 2026 7:40 PM

Action Behavior Centers, a leading provider of evidence-based applied behavior analysis (ABA) therapy for children diagnosed with autism spectrum disorder (ASD), reflected on a month of meaningful activities, family celebrations, and community engagement held throughout April in recognition of Autism Acceptance Month. April has long been recognized as Autism Acceptance Month, a time for schools, organizations, and communities to promote...

Read more

Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

May 6, 2026 5:15 PM

Moderna, Inc. (NASDAQ:MRNA) today announced a publication in the New England Journal of Medicine of the positive Phase 3 study results evaluating mRNA-1010, its vaccine candidate for seasonal influenza. The peer-reviewed article summarizes the safety and efficacy data from Moderna's Phase 3 study (P304) evaluating the relative vaccine efficacy (rVE) of mRNA-1010 against influenza illness compared to a licensed standard-dose seasonal influenza...

Read more

Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity

May 6, 2026 5:05 PM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the first quarter ended March 31, 2026. "Delivering 35% growth and achieving record year-over-year revenue for the 21st consecutive quarter reflects the consistency of our execution and the growing demand for...

Read more

Better Addiction Care Joins Communities Around the Country in Celebrating Mental Health Awareness Month

May 6, 2026 4:20 PM

Better Addiction Care, a leading informational resource and web guide connecting visitors with trusted mental health and addiction treatment providers, is highlighting Mental Health Awareness Month 2026. This year's campaign focuses on raising awareness, reducing stigma, and increasing access to treatment. To amplify the momentum of this national effort, Better Addiction Care is proud to announce its continued commitment to helping people find...

Read more

Aytu BioPharma to Report Fiscal 2026 Third Quarter Operational and Financial Results on May 13, 2026

May 6, 2026 4:05 PM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will report its operational and financial results for its third quarter of fiscal 2026, after the market close on Wednesday, May 13, 2026. The Company has scheduled a conference call and webcast that same day, Wednesday, May 13,...

Read more

Avel eCare Hosts National Emergency Airway Course, Earning Top Marks from Clinicians Across the Country

May 6, 2026 3:50 PM

Avel eCare welcomed emergency clinicians from across the country to Sioux Falls for its annual Emergency Airway Training Program, a two day, immersive course focused on one of the most critical and high risk emergency procedures: advanced airway management. Powered by The Difficult Airway Course™, the program combines evidence based instruction with intensive hands on training designed to help physicians, advanced practice providers, nurses, and...

Read more

Advanced Urology Alpharetta Ambulatory Surgery Center Named Among 2026 Best Ambulatory Surgery Centers by U.S. News & World Report

May 6, 2026 3:25 PM

Advanced Urology today announced that its Alpharetta ambulatory surgery center has been named among the 2026 Best Ambulatory Surgery Centers by U.S. News & World Report, a recognition that places the facility in the top tier of outpatient surgical centers nationwide. The 2026 ratings, released by U.S. News in March, evaluated more than 4,400 ambulatory surgery centers across the country and recognized 911 facilities, or roughly 21 percent, as...

Read more

Cosmos Health Introduces Fort18 in the United States - A Men's Sexual Stamina Supplement Expanding the 18 Series into Men's Wellness

May 6, 2026 10:35 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the introduction of Fort18™ in the United States - a men's sexual stamina supplement formulated with a proprietary blend of botanical extracts and nutrients that has been evaluated in published clinical research. Fort18™ is the latest addition to the Company's "18 Series," entering a large and growing...

Read more

Nurses Week Report: FBI Cyber Warning Puts Hospital Nurses' Downtime Readiness in Focus

May 6, 2026 9:35 AM

Black Book Research today released findings from a national survey of 480 registered nurses examining hospital cyber-downtime readiness from the bedside perspective, as National Nurses Week begins amid heightened federal concern over cyber risks facing hospitals and health systems. The report, "The Nurse Cyber-Downtime Gap" reframes hospital cybersecurity as a clinical-continuity and patient-safety issue, focusing on whether nurses can safely...

Read more

Jaguar Health Announces Preliminary Discussion with FDA to Evaluate Breakthrough Therapy Designation for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID)

May 6, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") family company Napo Pharmaceuticals Inc., announced that the Company recently held a preliminary discussion with the Division of Gastroenterology at U.S. Food and Drug Administration (FDA) to evaluate the possibility of a Breakthrough Therapy Designation (BTD) for oral liquid crofelemer as an adjunctive therapy to PS for the treatment of pediatric patients with intestinal failure (IF) due to...

Read more

Aptevo Reports 87% Clinical Benefit and 81% Remission in 31 Evaluable Frontline AML Patients Through Cohort 5, Substantially Outperforming Benchmark; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection

May 6, 2026 8:05 AM

Aptevo Therapeutics Inc. (Nasdaq:APVO) today reported new clinical results from its RAINIER frontline acute myeloid leukemia (AML) trial. The Company is on track to complete the Phase 1b dose-optimization trial and select the recommended Phase 2 dose (RP2D) this year. As with the current study, the Phase 2 trial will dose mipletamig in combination with venetoclax and azacitidine. Across 31 evaluable frontline AML patients treated to date...

Read more

Dr. Ran Rubinstein Introduces Renuva(R): A Breakthrough Non-Surgical Fat Restoration Treatment in New York and New Jersey

May 6, 2026 8:00 AM

Ran Y. Rubinstein, MD, a double board-certified facial plastic surgeon serving patients throughout New York and New Jersey, has announced the addition of Renuva® to his practice's non-surgical treatment menu. The injectable treatment is now available at Laser & Cosmetic Surgery Specialists in Newburgh, NY and Rubinstein Plastic Surgery Center in Montvale, NJ, offering patients in the Hudson Valley and Bergen County a new option for addressing...

Read more

Mach7 Appoints Brian Wehrle as Chief Technology Officer

May 6, 2026 6:00 AM

Mach7 Technologies, a leading provider of enterprise imaging solutions, today announced the appointment of Brian Wehrle as Chief Technology Officer (CTO). In this role, Wehrle will lead the company's global engineering and technology strategy, accelerating innovation across Mach7's enterprise imaging platform. Wehrle brings more than 25 years of experience in healthcare technology, software engineering, and product development. Most recently, he...

Read more

Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference

May 6, 2026 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations, will be presenting at the 2026 Bank of America Health Care Conference on Wednesday, May 13, 2026, at 3:00 pm PT. For access to the webcast, visit Amphastar Pharmaceuticals' website at http://ir.amphastar.com. This webcast will be available for 30 days following the presentation. About Amphastar...

Read more

Spago Nanomedical's Phase I/IIa study Tumorad-01 Meets a Primary Endpoint and Provides Further Visible Tumor Uptake

May 6, 2026 5:10 AM

Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) - Spago Nanomedical AB (publ) announced today that the independent Data Monitoring Committee (DMC) of the Tumorad-01 study declared that a primary endpoint, identifying the maximum tolerated dose, has been met and recommends that an additional two patients are enrolled at the dose level of 15 MBq/kg to provide a basis for defining a recommended phase II dose and completion of the phase I part of the...

Read more